D.E. Shaw & Co’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.32M	Sell	6,600 -1,000	-13%	-$198K	﹤0.01%	3231
2025 Q4	$1.44M	Buy	7,600 +6,000	+375%	+$1.15M	﹤0.01%	3296
2025 Q3	$283K	Buy	+1,600	New	+$238K	﹤0.01%	4140
2021 Q3	–	Sell	-16,030	Closed	-$1.31M	–	5112
2021 Q2	$1.31M	Hold	16,030	–	–	﹤0.01%	3324
2021 Q1	$1.52M	Buy	+16,030	New	+$1.52M	﹤0.01%	2806
2019 Q4	–	Sell	-58,510	Closed	-$3.63M	–	4103
2019 Q3	$3.63M	Sell	58,510 -32,060	-35%	-$2.01M	0.01%	1882
2019 Q2	$6.45M	Buy	90,570 +82,876	+1,077%	+$6.1M	0.01%	1423
2019 Q1	$603K	Sell	7,694 -11,061	-59%	-$838K	﹤0.01%	2898
2018 Q4	$1.59M	Sell	18,755 -28,373	-60%	-$3.02M	﹤0.01%	2345
2018 Q3	$8.07M	Buy	47,128 +18,755	+66%	+$2.83M	0.01%	1239
2018 Q2	$3.67M	Buy	28,373 +12,343	+77%	+$1.38M	0.01%	1753
2018 Q1	$1.65M	Hold	16,030	–	–	﹤0.01%	2175
2017 Q4	$1.37M	Buy	+16,030	New	+$1.39M	﹤0.01%	2391
2017 Q1	–	Sell	-16,030	Closed	-$1.02M	–	3486
2016 Q4	$1.02M	Buy	+16,030	New	+$1.01M	﹤0.01%	2449
2016 Q1	–	Sell	-9,939	Closed	-$672K	–	3642
2015 Q4	$672K	Hold	9,939	–	–	﹤0.01%	2896
2015 Q3	$531K	Buy	+9,939	New	+$603K	﹤0.01%	3022
2014 Q3	–	Sell	-16,030	Closed	-$623K	–	4295
2014 Q2	$623K	Sell	16,030 -42,319	-73%	-$1.72M	﹤0.01%	3340
2014 Q1	$2.45M	Buy	58,349 +49,372	+550%	+$2.06M	0.01%	2188
2013 Q4	$295K	Sell	8,977 -33,342	-79%	-$1.09M	﹤0.01%	4068
2013 Q3	$1.14M	Sell	42,319 -13,946	-25%	-$392K	﹤0.01%	2909
2013 Q2	$1.31M	Buy	+56,265	New	+$1.01M	﹤0.01%	2486